Back to today’s briefing

Story perspectives

FDA-Approved Cancer Drugs Show Promise Against Alzheimer's

7/25/2025

33 2

Summary

Story summary

In a groundbreaking discovery, UCSF researchers have found that the cancer drugs letrozole and irinotecan may hold the key to treating Alzheimer's disease. These FDA-approved medications demonstrated the ability to reverse harmful gene changes and diminish tau protein clumps in mice. Exciting clinical trials for human patients are on the horizon, offering hope to the 55 million people battling Alzheimer's worldwide.

1 of 1

Story summary

In a groundbreaking discovery, UCSF researchers have found that the cancer drugs letrozole and irinotecan may hold the key to treating Alzheimer's disease. These FDA-approved medications demonstrated the ability to reverse harmful gene changes and diminish tau protein clumps in mice. Exciting clinical trials for human patients are on the horizon, offering hope to the 55 million people battling Alzheimer's worldwide.